Jan 11, 2022 / 02:00PM GMT
Richard Vosser - JPMorgan Chase & Co, Research Division - Senior Analyst
Welcome to day 2 at the JPMorgan Healthcare Conference. I'm Richard Vosser, European pharma analyst with JPMorgan, and it's my great pleasure to host in this session, Merck KGaA from Darmstadt in Germany and the CEO of Merck, Belen Garijo. Before I hand over to Belen, I'd just point out that if you would like to ask questions during this session, please post them to the conference portal, and then I'll read them out for you, and we can ask Belen that way. With that, welcome to the conference, Belen. Good to see you, and over to you.
Belen Garijo Lopez - MERCK Kommanditgesellschaft auf Aktien - Chair of Executive Board & CEO
Thank you, Richard. Good to see you, too, and many thanks to JPMorgan for the invite. Ladies and gentlemen, a very warm welcome from my side, and a happy and healthy New Year to all of you. It's a true pleasure to be here with you today, and we kindly appreciate your interest in our company.
As usual, I will spend the first 15 minutes walking you through
Merck KGaA at JPMorgan Healthcare Conference (Virtual) Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot